Comparative proteome analysis of form-deprivation myopia in sclera with iTRAQ-based quantitative proteomics.
Actins
/ metabolism
Animals
Blotting, Western
Chromatography, Liquid
Computational Biology
Cytoskeletal Proteins
/ metabolism
Disease Models, Animal
GTP-Binding Proteins
/ metabolism
Gene Ontology
Guinea Pigs
Myopia
/ metabolism
Nonmuscle Myosin Type IIB
/ metabolism
Proteome
/ metabolism
Proteomics
/ methods
Real-Time Polymerase Chain Reaction
Sclera
/ metabolism
Sensory Deprivation
Tandem Mass Spectrometry
rap1 GTP-Binding Proteins
/ metabolism
rhoA GTP-Binding Protein
/ metabolism
Journal
Molecular vision
ISSN: 1090-0535
Titre abrégé: Mol Vis
Pays: United States
ID NLM: 9605351
Informations de publication
Date de publication:
2021
2021
Historique:
received:
02
05
2020
accepted:
30
08
2021
entrez:
16
9
2021
pubmed:
17
9
2021
medline:
1
1
2022
Statut:
epublish
Résumé
Scleral remodeling plays a key role in axial elongation in myopia. The aim of the present study was to identify the proteomics changes and specific signaling networks to gain insight into the molecular basis of scleral remodeling in myopic eyes. Guinea pig form-deprivation myopia was induced with a translucent diffuser on a random eye for 4 weeks, while the other eye served as the contralateral control group. The axial length and refraction were measured at the beginning and end of the treatment. The proteins were extracted from the sclerae of each group and prepared for quantitative isobaric tags for relative and absolute quantification (iTRAQ) labeling combined with liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis. The coexpression networks and protein functions were analyzed using Gene Ontology (GO) and Ingenuity Pathway Analysis (IPA). Quantitative real-time PCR (qRT-PCR) and western blotting were performed to confirm the authenticity and accuracy of the iTRAQ results. After 4 weeks, the form-deprivation eyes developed significant degrees of myopia, and the axial length increased statistically significantly (p<0.05). A total of 2,579 unique proteins with <1% false discovery rate (FDR) were identified. Furthermore, 56 proteins were found to be upregulated, and 84 proteins were found to be downregulated, with a threshold of a 1.2-fold change and p<0.05 in the myopia group, when compared to the control group. Further bioinformatics analysis indicated that 44 of 140 differentially expressed proteins were involved in cellular movement and cellular assembly and organization. The qRT-PCR or western blotting results confirmed that myosin IIB, ACTIN3, and cellular cytoskeletons were downregulated, while RhoA and RAP1A were upregulated in the sclera in myopic eyes. These results were consistent with the proteomics results. Proteomics and bioinformatics results can be helpful for identifying proteins and providing new insights for better understanding of the molecular mechanism underlying scleral remodeling. These results revealed that the proteins associated with cellular movement and cellular assembly and organization are altered during the development of myopia. Furthermore, RhoA plays a key role in the pathways involved in cellular movement and cellular assembly and organization.
Substances chimiques
Actins
0
Cytoskeletal Proteins
0
Proteome
0
GTP-Binding Proteins
EC 3.6.1.-
Nonmuscle Myosin Type IIB
EC 3.6.1.-
rap1 GTP-Binding Proteins
EC 3.6.5.2
rhoA GTP-Binding Protein
EC 3.6.5.2
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
494-505Informations de copyright
Copyright © 2021 Molecular Vision.
Références
Metab Pediatr Syst Ophthalmol. 1983;7(4):183-8
pubmed: 6678372
Invest Ophthalmol Vis Sci. 2015 Mar 03;56(3):2065-78
pubmed: 25736788
Invest Ophthalmol Vis Sci. 2013 Mar 11;54(3):1767-80
pubmed: 23404116
J Proteome Res. 2014 Nov 7;13(11):4647-58
pubmed: 25211393
Dev Biol. 2015 Jan 1;397(1):103-15
pubmed: 25446029
Ophthalmology. 2007 Feb;114(2):374-82
pubmed: 17123622
Mol Vis. 2015 Feb 06;21:138-47
pubmed: 25684979
Invest Ophthalmol Vis Sci. 2000 Nov;41(12):3713-9
pubmed: 11053267
Invest Ophthalmol Vis Sci. 2005 Oct;46(10):3484-92
pubmed: 16186323
Mol Med. 2016 Dec;22:713-723
pubmed: 27704140
J Proteome Res. 2007 Nov;6(11):4135-49
pubmed: 17924678
Nat Rev Mol Cell Biol. 2008 Sep;9(9):690-701
pubmed: 18719708
Cytokine. 2002 Jun 21;18(6):344-8
pubmed: 12160524
Lab Invest. 2011 Apr;91(4):499-508
pubmed: 21102503
Optom Vis Sci. 2009 Jan;86(1):E23-30
pubmed: 19104466
Mol Cell Proteomics. 2012 Jun;11(6):M111.014423
pubmed: 22210691
Eye (Lond). 2014 Feb;28(2):113-7
pubmed: 24113300
Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3619-3629
pubmed: 30029249
J Ophthalmol. 2016;2016:5126560
pubmed: 27247798
Exp Eye Res. 2004 Mar;78(3):609-23
pubmed: 15106941
Br J Ophthalmol. 2016 Jul;100(7):882-890
pubmed: 26802174
Graefes Arch Clin Exp Ophthalmol. 2012 Jul;250(7):1009-12
pubmed: 22407293
Invest Ophthalmol Vis Sci. 2012 Jan 25;53(1):322-36
pubmed: 22039233
Graefes Arch Clin Exp Ophthalmol. 1990;228(2):174-9
pubmed: 2338255
Brief Funct Genomic Proteomic. 2006 Jun;5(2):112-20
pubmed: 16772272
J Cell Biol. 2010 Mar 22;188(6):877-90
pubmed: 20308429
Eye (Lond). 1987;1 ( Pt 2):175-83
pubmed: 3308525
Proc Natl Acad Sci U S A. 2018 Jul 24;115(30):E7091-E7100
pubmed: 29987045
Mol Biol Cell. 2010 Nov 15;21(22):3952-62
pubmed: 20861308
Curr Eye Res. 2018 Feb;43(2):200-207
pubmed: 29135319
Mol Biol Cell. 2006 Jan;17(1):43-55
pubmed: 16236794
Invest Ophthalmol Vis Sci. 2001 Sep;42(10):2179-87
pubmed: 11527928
Mol Vis. 2011;17:1334-42
pubmed: 21647271
Mol Med Rep. 2018 Apr;17(4):5571-5580
pubmed: 29436656
PLoS One. 2016 Oct 6;11(10):e0163165
pubmed: 27711221
J Cell Sci. 2008 Jan 1;121(Pt 1):11-8
pubmed: 18096687
Curr Mol Med. 2014 Feb;14(2):199-208
pubmed: 24467208
Mol Vis. 2016 Jan 29;22:82-99
pubmed: 26900327
Scand J Med Sci Sports. 2009 Aug;19(4):490-9
pubmed: 19422655
Invest Ophthalmol Vis Sci. 2007 Jul;48(7):2957-66
pubmed: 17591860
Invest Ophthalmol Vis Sci. 1997 Nov;38(12):2435-46
pubmed: 9375560
J Cell Biol. 2010 Jun 28;189(7):1107-15
pubmed: 20584916
Mol Vis. 2010 Oct 27;16:2163-74
pubmed: 21139681
Nat Cell Biol. 2008 Sep;10(9):1039-50
pubmed: 19160484
J R Soc Interface. 2014 Mar 19;11(95):20131072
pubmed: 24647903
J Cell Sci. 2017 Aug 15;130(16):2696-2706
pubmed: 28687623